Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
Main Authors: | Ning Zhu, Hanguang Hu, Ying Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-09-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-022-01164-y |
Similar Items
-
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
by: Shu‐Qiang Yuan, et al.
Published: (2023-12-01) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
by: Midgley, R, et al.
Published: (2005) -
Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer
by: Wenhua Fan, et al.
Published: (2024-01-01) -
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
by: Adrien Grancher, et al.
Published: (2022-11-01) -
Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment
by: Asimina Koulouridi, et al.
Published: (2021-07-01)